Beyond serum creatinine: which tools to evaluate renal function in cirrhotic patients?

Area of Science:

• Nephrology
• Hepatology
• Clinical Chemistry

Background:

• Elevated serum creatinine indicates mortality risk in cirrhotic patients and predicts renal insufficiency post-liver transplant.
• Chronic kidney disease is an independent mortality factor in liver disease patients.

Purpose of the Study:

• To highlight the critical need for accurate glomerular filtration rate (GFR) assessment in end-stage liver disease and liver transplantation.
• To evaluate current GFR estimation methods and explore potential alternatives.

Main Methods:

• Review of existing literature on GFR assessment in liver disease.
• Analysis of the limitations of serum creatinine and creatinine-based equations.
• Discussion of alternative markers like Cystatin C and emerging technologies.

Main Results:

• Serum creatinine and creatinine-based equations significantly overestimate renal function in cirrhotic patients.
• Equilibrium inulin renal clearance is accurate but impractical for routine use.
• Cystatin C offers advantages but lacks standardization and is costly.

Conclusions:

• Accurate GFR measurement is vital for managing liver disease patients, especially those undergoing transplantation.
• Current clinical tools for GFR estimation are suboptimal, necessitating further research into reliable and practical methods.
• Novel biomarkers and imaging techniques show promise but require defined clinical applications.